DEV Community

devsouq
devsouq

Posted on

Building a Decentralized Clinical Trial Platform | Technical Architecture, APIs, Compliance, and Build-vs-Buy

DevSouq Technologies decentralized clinical trial platform featuring a clinical trial management dashboard, remote patient participation, eConsent, telehealth visits, real-time data analytics, and global participant tracking.

Building a Decentralized Clinical Trial Platform: Technical Architecture, APIs, Compliance, and Build-vs-Buy

Quick Answer

A decentralized clinical trial (DCT) platform supports clinical research activities outside traditional trial sites through technologies such as eConsent, ePRO/eCOA, telehealth, electronic data capture, and connected devices.Building one requires more than a participant-facing mobile app. Developers must consider clinical workflows, data integrity, integrations, security, audit trails, and regulatory requirements.The right approach depends on the trial protocol, participant needs, integration complexity, and long-term operating costs. DevSouq Technologies helps organizations evaluate custom clinical software when standard platforms do not fit their workflows.

What Is a Decentralized Clinical Trial Platform?

A decentralized clinical trial platform is a software environment that supports some or all trial-related activities remotely, allowing participants to complete selected tasks without visiting a traditional research site for every interaction.

Depending on the protocol, these activities may include:

  • Remote participant screening and enrollment
  • Electronic informed consent
  • Patient-reported outcome collection
  • Telehealth consultations
  • Remote monitoring
  • Wearable and device-based data collection
  • Electronic data capture
  • Participant communication and follow-ups

Not every clinical trial can be fully decentralized. Some assessments, procedures, and safety checks still require in-person visits. Hybrid models are therefore common.

From a development perspective, the important point is that a DCT platform must support the actual trial workflow rather than simply provide a collection of remote communication features.

The Mobile App Is Only One Part of the System

A common development mistake is treating the participant mobile application as the entire decentralized trial solution.

The mobile app is only one part of the environment. A complete platform may also need:

  • A participant portal
  • Researcher and site staff interfaces
  • Electronic data capture
  • eConsent management
  • ePRO and eCOA workflows
  • Device and wearable integrations
  • Administrative controls
  • Reporting and data export
  • External system integrations

Each component serves a different role, and the platform must keep their data and workflows consistent.

For example, when a participant submits a questionnaire, the platform needs to associate that response with the correct participant, study, visit, and assessment. It must also preserve the relevant timestamps and records for review.

This is a data architecture and workflow challenge, not just a mobile application development task.

Core Components Developers Need to Consider

1. Participant Application

The participant application is often the primary interface for people taking part in a decentralized or hybrid clinical trial.

Depending on the study, it may support:

  • Registration and onboarding
  • Study instructions
  • Appointment scheduling
  • Questionnaires and assessments
  • Medication or visit reminders
  • Telehealth access
  • Notifications
  • Support requests

The application should be designed around the participant's actual study journey.

A complicated interface can make it harder for participants to complete required activities. Clear instructions, accessible design, and predictable navigation are therefore important.

Developers should also consider offline or low-connectivity situations where participants may not have reliable internet access.

2. Electronic Informed Consent

Electronic informed consent allows participants to review study information and complete consent-related steps digitally.

A well-designed eConsent workflow may include:

  • Presentation of consent documents
  • Version management
  • Participant comprehension checks where required
  • Electronic signatures
  • Consent timestamps
  • Records of document access and completion
  • Re-consent workflows when documents change

Consent records need to remain connected to the correct participant and study.

Developers working on this component should pay particular attention to document versioning, identity verification requirements, record retention, and auditability.

For a deeper look at the development considerations behind this component, see our related article on eConsent software for clinical trials.

3. Electronic Data Capture

Electronic data capture (EDC) is responsible for collecting and managing clinical study data.

Depending on the protocol, an EDC system may handle:

  • Case report forms
  • Participant and visit records
  • Clinical assessments
  • Data validation
  • Query management
  • Data review
  • Audit trails
  • Data exports

The data model should reflect the study design. Developers need to consider how participants, sites, visits, forms, assessments, and study events relate to one another.

Poor data modeling can create problems later when teams need to reconcile records, manage protocol changes, or prepare data for analysis.

4. ePRO and eCOA

Electronic patient-reported outcomes (ePRO) and electronic clinical outcome assessments (eCOA) allow participants to submit information through digital interfaces.

These tools may collect:

  • Symptoms
  • Daily health observations
  • Treatment experiences
  • Quality-of-life responses
  • Study-specific questionnaires

The development team should consider questionnaire scheduling, response validation, reminders, missing responses, and timestamp accuracy.

The platform should also preserve the relationship between each response and the relevant assessment schedule.

5. Wearables and Connected Devices

Some decentralized trials use wearable devices and remote monitoring tools to collect data outside clinical sites.

Potential sources include activity trackers, connected medical devices, and other protocol-approved monitoring equipment.

Integration requirements vary by device and study. Before implementation, developers should establish:

  • Which device data is required
  • How frequently data should be collected
  • How device identity is associated with a participant
  • How missing or delayed data is handled
  • How incoming measurements are validated
  • How data is stored and made available for review

Device integration should be based on the protocol's actual requirements. Collecting additional data without a clear purpose can increase system complexity.

API and Integration Design

A DCT platform may need to exchange information with several external systems, including electronic health records, laboratories, telehealth services, wearable platforms, and clinical trial management systems.

This makes integration planning an important part of the architecture.

Developers should evaluate:

API authentication: External connections should use appropriate authentication and authorization controls.

Data validation: Incoming data should be checked before it becomes part of a clinical record.

Error handling: Failed requests, unavailable services, and incomplete transfers should be handled without silently losing information.

Data mapping: Different systems may use different formats and terminology. Mapping rules should be defined and tested.

Integration monitoring: Teams need visibility into failed transfers, delayed events, and synchronization problems.

Where appropriate, healthcare interoperability standards such as HL7 FHIR may help systems exchange structured information. However, the specific standard and implementation depend on the systems involved.

Integration should be planned early rather than treated as a final development task.

Security and Access Control

Clinical trial platforms handle sensitive participant and research information. Security must therefore be considered throughout the development process.

Important areas include:

  • Role-based access control
  • Strong authentication
  • Encryption in transit and at rest
  • Session management
  • Secure API communication
  • Access logging
  • Data backup and recovery
  • Retention and deletion policies

Access should be limited according to each user's responsibilities. A participant, investigator, site coordinator, monitor, and administrator should not automatically have the same permissions.

Healthcare software projects also need to consider how patient information is protected across different applications and workflows. Our article on building behavioral health EHR software discusses related requirements around healthcare data, system functionality, and software design.

The exact security and privacy requirements for a DCT platform depend on the trial locations, organizations involved, data types, and applicable regulations.

Why Audit Trails Matter

An audit trail records important actions and changes within a clinical system.

For example, a platform may need to record:

  • Who created or modified a record
  • When an action occurred
  • Which information changed
  • The previous and updated values, where required
  • The reason for a change, where applicable

Audit trails support traceability and help authorized reviewers understand how clinical records have changed over time.

Developers should avoid treating audit logging as a simple activity history. The implementation should reflect the system's compliance requirements and preserve records in a way that supports review.

Managing Protocol Amendments

Clinical trial protocols can change during a study.

An amendment may affect eligibility criteria, questionnaires, visit schedules, consent documents, or data collection requirements.

A platform should be designed to manage these changes without creating confusion between old and new study requirements.

Developers should consider:

  • Version-controlled study configurations
  • Effective dates for changes
  • Updated assessment schedules
  • Re-consent requirements
  • Historical record preservation
  • Clear communication of changes to relevant users

A system that requires extensive manual changes every time a protocol is updated may become difficult to maintain as the study grows.

Interoperability Should Be Evaluated Early

Interoperability is not simply about whether two systems have APIs.

A successful integration must also account for data meaning, identifiers, permissions, validation, and workflow differences.

For example, a laboratory result may arrive in a different format from the one expected by the clinical data system. The platform needs a defined process for matching, validating, and storing that result.

Before development begins, teams should identify:

  1. Which external systems need to connect.
  2. What information must be exchanged.
  3. Which system is the source of truth for each data element.
  4. How records will be matched across systems.
  5. How integration errors will be monitored and resolved.

This reduces the risk of building integrations that work technically but fail to support the actual research workflow.

Build vs. Buy: Which Approach Makes Sense?

The decision to build or buy depends on the trial's requirements, available resources, integration needs, and expected operating costs.

When Buying an Existing Platform Makes Sense

An established platform may be suitable when:

  • Standard clinical workflows meet the study requirements.
  • Required features are already available.
  • Existing integrations cover the necessary systems.
  • The licensing model fits the budget.
  • The vendor can support the required validation and documentation.

Buying can reduce the amount of software that an organization needs to develop and maintain itself.

However, teams should review configuration limits, recurring fees, data access, integration costs, and contract terms before making a decision.

When Custom Development May Be Worth Considering

Custom development may be appropriate when:

  • The study has unusual data collection requirements.
  • Existing platforms cannot support important workflows.
  • Several internal or external systems need specialized integration.
  • The organization needs greater control over its software roadmap.
  • Licensing or per-user costs become difficult to manage.

Custom software requires planning, testing, maintenance, and appropriate compliance controls. It is not automatically cheaper or better than an established product.

DevSouq Technologies works with organizations evaluating custom healthcare and clinical software solutions when standard products do not adequately match their requirements.

The practical starting point is to define the workflows, integrations, compliance needs, and long-term costs before choosing a development approach.

Questions to Ask a DCT Platform Vendor

Before selecting a platform, clinical research teams should ask:

  1. Which decentralized trial workflows does the platform support?
  2. Can it handle hybrid trial models?
  3. How does it manage eConsent and consent document versions?
  4. What EDC, ePRO, and eCOA capabilities are included?
  5. Which wearable devices and external systems can it integrate with?
  6. How are audit trails and record changes handled?
  7. Can the platform support protocol amendments?
  8. What data export options are available?
  9. How are user roles and permissions managed?
  10. What are the implementation, licensing, integration, and maintenance costs?

The answers should be evaluated against the actual study requirements rather than a generic feature checklist.

Common Engineering Mistakes

Treating the Mobile App as the Entire Platform

A participant-facing application cannot replace the clinical data, administrative, integration, and oversight capabilities needed by a trial.

Planning Integrations Too Late

External systems may have different data structures, authentication requirements, and limitations. Delayed integration planning can create expensive rework.

Underestimating Data Quality

Missing values, duplicate records, inconsistent identifiers, and incorrect timestamps can affect the reliability of clinical data.

Ignoring Protocol Changes

A system that cannot manage evolving study requirements may become difficult to operate and maintain.

Confusing Feature Availability with Compliance

Having an electronic signature, audit log, or encryption feature does not automatically make a platform compliant. The complete system, its configuration, validation, procedures, and intended use all matter.

Practical Evaluation Checklist

Before selecting or developing a DCT platform, review these areas:

  • Participant application and accessibility
  • eConsent and document versioning
  • EDC and clinical data management
  • ePRO/eCOA assessment workflows
  • Wearable and device integrations
  • Telehealth and remote communication
  • API security and interoperability
  • Role-based access control
  • Audit trails and data traceability
  • Protocol amendment management
  • Data export and reporting
  • Implementation and maintenance costs

This checklist can help teams identify gaps before committing to a vendor or development project.

Where Custom Development Can Fit

Not every clinical trial fits neatly into a standard software package.

A research organization may need a particular combination of participant workflows, data collection forms, device integrations, reporting capabilities, or internal systems.

In these situations, custom development can provide more control over how the platform is structured.

The decision should still be based on a clear requirements assessment. Teams should compare the cost and complexity of customization against the benefits of using an existing product.

DevSouq Technologies offers a Scope Clarity Session for organizations that want to evaluate their software requirements, expected costs, timelines, and potential implementation risks before deciding whether to build, buy, or integrate.

Final Thoughts

A decentralized clinical trial platform is a connected clinical software environment, not simply a mobile application.

Its success depends on how well participant-facing tools, clinical data workflows, integrations, security controls, and protocol requirements work together.

For developers and research organizations, the most important step is to understand the trial workflow before selecting technologies or designing the system.

A platform should be evaluated by how reliably it supports the study—not by how many features appear on its product page.

FAQs

1. What software is needed for a decentralized clinical trial?

A decentralized trial may require eConsent, EDC, ePRO/eCOA, participant applications, telehealth, device integrations, reporting, and administrative tools. The exact combination depends on the protocol.

2. What is the difference between a decentralized and hybrid clinical trial?

A decentralized trial conducts some or all trial activities remotely. A hybrid trial combines remote activities with selected in-person visits at traditional research sites.

3. Why is eConsent important in decentralized clinical trials?

eConsent allows participants to review study information and complete consent-related steps digitally. The system should support appropriate document versions, signatures, timestamps, and traceable records.

4. Should organizations build or buy a decentralized clinical trial platform?

Buying may be suitable when existing products support the required workflows and integrations. Custom development may be worth evaluating when the trial has specialized requirements or significant integration needs.

5. What are the main technical challenges in developing a DCT platform?

Common challenges include clinical data integrity, interoperability, secure access, audit trails, device integration, protocol amendments, and maintaining consistent workflows across different systems.

Top comments (0)